ETFMG Alternative Harvest ETF (MJ)

13.85 -0.02  -0.14% NYSE Arca Jun 2, 20:00 Delayed 2m USD
View Full Chart
Price Chart

Key Stats

Net Asset Value 13.84
Discount or Premium to NAV 0.07%
Turnover Ratio 71.00%
1 Year Fund Level Flows 142.50M

Performance & Returns

  Total Return (Price) Total Return (NAV) Cat. Total Return (NAV) % Rank in Cat. (NAV)
1M 19.91% 19.72% -- --
3M -1.55% -1.84% -- --
6M -15.69% -16.00% -- --
YTD -18.29% -18.06% -- --
1Y -53.12% -53.18% -- --
3Y -19.46% -18.61% -- --
5Y -- -- -- --
10Y -- -- -- --
15Y -- -- -- --
20Y -- -- -- --
As of June 2, 2020. Returns for periods of 1 year and above are annualized.

Asset Allocation

Type % Net % Long % Short
Cash 0.57% 0.57% 0.00%
Stock 99.43% 99.43% 0.00%
Bond 0.00% 0.00% 0.00%
Convertible 0.00% 0.00% 0.00%
Preferred 0.00% 0.00% 0.00%
Other 0.00% 0.00% 0.00%
As of May 29, 2020

Region Exposure

Americas 79.67%
North America 79.67%
Latin America 0.00%
Greater Europe 17.82%
United Kingdom 14.58%
Europe Developed 3.24%
Europe Emerging 0.00%
Africa/Middle East 0.00%
Greater Asia 2.51%
Japan 2.51%
Australasia 0.00%
Asia Developed 0.00%
Asia Emerging 0.00%
Market Classification
% Developed Markets 100.0%
% Emerging Markets 0.00%
As of May 29, 2020. Region breakdown data is calculated by using the long position holdings of the portfolio.

Stock Sector Exposure

Basic Materials 5.37%
Communication Services 0.00%
Consumer Cyclical 0.00%
Consumer Defensive 24.80%
Energy 0.00%
Financial Services 0.00%
Healthcare 69.83%
Industrials 0.00%
Real Estate 0.00%
Technology 0.00%
Utilities 0.00%
As of May 29, 2020

Stock Market Capitalization

Giant 7.18%
Large 4.27%
Medium 24.55%
Small 37.48%
Micro 26.52%
As of May 29, 2020

Stock Style Exposure

Large Cap Value 13.46%
Large Cap Blend 0.00%
Large Cap Growth 0.00%
Mid Cap Value 0.00%
Mid Cap Blend 0.00%
Mid Cap Growth 16.90%
Small Cap Value 6.72%
Small Cap Blend 6.08%
Small Cap Growth 56.84%
As of May 29, 2020
View More Holdings

Top 10 Holdings

Symbol Name % Weight Price % Chg
GWPH GW Pharmaceuticals PLC ADR 10.11% 127.27 +2.00%
CRON.TO Cronos Group Inc 9.07% 8.67 -3.45%
WEED.TO Canopy Growth Corp 7.99% 21.78 -2.16%
ACB.TO Aurora Cannabis Inc 5.69% 19.58 +1.82%
TLRY Tilray Inc 5.40% 10.02 -0.20%
CRBP Corbus Pharmaceuticals Holdings Inc 4.75% 7.05 -3.56%
APHA.TO Aphria Inc 4.69% 6.07 +1.17%
OGI.TO OrganiGram Holdings Inc 3.61% 2.42 -2.02%
SWMA Swedish Match AB 3.22% -- --
ARNA Arena Pharmaceuticals Inc 3.16% 68.22 +16.22%
As of May 29, 2020
Advertisement

Basic Info

Investment Strategy
The investment seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of the Prime Alternative Harvest Index. The fund will invest at least 80% of its total assets, exclusive of collateral held from securities lending, in the component securities of the index and in ADRs and GDRs based on the component securities in the index. The index is concentrated in the Pharmaceuticals, Biotechnology and Life Sciences group of industries and tracks the performance of the exchange-listed common stock (or corresponding ADRs or GDRs) of companies across the globe. The fund is non-diversified.
General
Security Type Exchange-Traded Fund
Equity Style Small Cap/Growth
Fixed Income Style --
Broad Asset Class Sector Equity
Broad Category Equity
Category Name Miscellaneous Sector
Prospectus Objective Specialty - Unaligned
Fund Owner Firm Name ETFMG
Benchmark Index
Prime Alternative Harvest NR USD 100.0%
Reports
One Page Report Download

Manager Info

Name Tenure
Devin Ryder 1.98 yrs
Donal Bishnoi 0.58 yrs
Frank Vallario 0.58 yrs
Samuel Masucci 1.98 yrs

Net Fund Flows

1M 4.974M
3M -14.13M
6M 47.91M
YTD 19.80M
1Y 142.50M
3Y --
5Y --
10Y --
As of May 31, 2020

Risk Info

Beta (5Y) --
Max Drawdown (All) 77.35%
Historical Sharpe Ratio (10Y) --
Historical Sortino (All) -0.0743
30-Day Rolling Volatility 51.53%
Daily Value at Risk (VaR) 1% (All) 6.80%
Monthly Value at Risk (VaR) 1% (All) 26.99%

Fundamentals

Dividend Yield TTM (6-2-20) 6.35%
30-Day SEC Yield (5-1-20) 0.00%
7-Day SEC Yield --
Weighted Average PE Ratio --
Weighted Average Price to Sales Ratio 2.727
Weighted Average Price to Book Ratio 1.206
Weighted Median ROE 1.42%
Weighted Median ROA -1.52%
Forecasted Dividend Yield 2.09%
Forecasted PE Ratio 15.03
Forecasted Price to Sales Ratio 1.345
Forecasted Price to Book Ratio 0.4723
Number of Holdings 37
As of May 29, 2020

Growth Estimates

Forecasted 5 Yr Earnings Growth 9.24%
Forecasted Book Value Growth 44.13%
Forecasted Cash Flow Growth 5.86%
Forecasted Earnings Growth 6.48%
Forecasted Revenue Growth 11.86%
As of May 29, 2020

Comparables

Edit

Attributes

Key Dates
Inception Date 12/3/2015
Termination Date
Last Annual Report Date 9/30/2019
Last Prospectus Date 1/31/2020
Attributes
Exchange Traded Share Yes
Exchange Traded Note No
Enhanced Index Fund No
Fixed Distribution Fund No
High-Net Worth Individual Fund No
Index Fund Yes
Inverse Fund No
Leveraged Fund No
Fund of Funds No
Currency Hedged Fund No
Synthetic Replication Fund No
Has Dividend Investment Plan No
Socially Responsible Fund No
General Availability
Available for Insurance Product No
Available for Retirement Plan No
Available for RRSP No
Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.